Literature DB >> 14596945

Genetic factors in cardiovascular disease. 10 questions.

Aldons J Lusis1.   

Abstract

The common forms of cardiovascular disease (CVD) have a complex etiology, involving multiple genetic influences and important environmental interactions. Because of this complexity, it has proved difficult to apply the positional cloning approaches that have revolutionized understanding of Mendelian (single-gene) disorders; and the understanding of the genetics of CVD and its underlying cause, atherosclerosis, remains poor. This review, organized into 10 broad questions, summarizes the understanding of the genetics of common, complex forms of CVD. Implications for DNA-based diagnosis, pharmacogenetics, and risk assessment are also discussed.

Entities:  

Mesh:

Year:  2003        PMID: 14596945     DOI: 10.1016/j.tcm.2003.08.001

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  10 in total

Review 1.  The genetics of congestive heart failure.

Authors:  Calum A MacRae
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

2.  Lack of MEF2A mutations in coronary artery disease.

Authors:  Li Weng; Nihan Kavaslar; Anna Ustaszewska; Heather Doelle; Wendy Schackwitz; Sybil Hébert; Jonathan C Cohen; Ruth McPherson; Len A Pennacchio
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

3.  Lack of an association between connexin-37, stromelysin-1, plasminogen activator-inhibitor type 1 and lymphotoxin-alpha genes and acute coronary syndrome in Czech Caucasians.

Authors:  Jaroslav Alois Hubacek; Vladimír Staněk; Marie Gebauerová; Alexandra Pilipčincová; Rudolf Poledne; Michal Aschermann; Hana Skalická; Jana Matoušková; Andreas Kruger; Martin Pěnička; Hana Hrabáková; Josef Veselka; Petr Hájek; Vera Lánská; Věra Adámková; Jan Pit'ha
Journal:  Exp Clin Cardiol       Date:  2010

4.  The role of genetic predisposition in cardiovascular risk after cancer diagnosis: a matched cohort study of the UK Biobank.

Authors:  Huazhen Yang; Yu Zeng; Wenwen Chen; Yajing Sun; Yao Hu; Zhiye Ying; Junren Wang; Yuanyuan Qu; Fang Fang; Unnur A Valdimarsdóttir; Huan Song
Journal:  Br J Cancer       Date:  2022-08-24       Impact factor: 9.075

5.  CCR2 and coronary artery disease: a woscops substudy.

Authors:  David J Dow; Alex D McMahon; Ian C Gray; Chris J Packard; Pieter He Groot
Journal:  BMC Res Notes       Date:  2010-02-02

6.  Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease.

Authors:  Pamela A McCaskie; John P Beilby; Caroline M L Chapman; Joseph Hung; Brendan M McQuillan; Peter L Thompson; Lyle J Palmer
Journal:  Hum Genet       Date:  2007-02-08       Impact factor: 4.132

Review 7.  Using new tools to define the genetic underpinnings of risky traits associated with coronary artery disease: the SardiNIA study.

Authors:  James B Strait; Manuela Uda; Edward G Lakatta; Samer S Najjar
Journal:  Trends Cardiovasc Med       Date:  2009-04       Impact factor: 6.677

Review 8.  Variants in exon 11 of MEF2A gene and coronary artery disease: evidence from a case-control study, systematic review, and meta-analysis.

Authors:  Yan Liu; Wenquan Niu; Zhijun Wu; Xiuxiu Su; Qiujin Chen; Lin Lu; Wei Jin
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

9.  Genetic and genomic analysis of a fat mass trait with complex inheritance reveals marked sex specificity.

Authors:  Susanna Wang; Nadir Yehya; Eric E Schadt; Hui Wang; Thomas A Drake; Aldons J Lusis
Journal:  PLoS Genet       Date:  2006-02-03       Impact factor: 5.917

10.  Establishment of a quantitative in vivo method for estimating adipose tissue volumes and the effects of dietary soy sauce oil on adipogenesis in medaka, Oryzias latipes.

Authors:  Yasuhiro Tonoyama; Masaki Tsukada; Yoshimasa Imai; Matoki Sanada; Syota Aota; Gouhei Oka; Shozo Sugiura; Nobuaki Hori; Hiroyuki Kawachi; Yoshiko Shimizu; Nobuyoshi Shimizu
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.